Suven Life gets product patents from New Zealand, US
Suven Life Sciences today said it has been granted a product patent by New Zealand and the US, each corresponding to a new chemical entity (NCE) for29-05-2018
29-05-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in New Zealand and USA29-05-2018
Suven Life gets product patents from New Zealand, Norway
Suven Life Sciences on Tuesday said that it has been granted one product patent each from New Zealand and Norway corresponding to the new chemical ent22-05-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in New Zealand and Norway22-05-2018
Reply To Clarification- Financial Results
The following Note No. 5 forming part of the Annual Audited Financial Results furnished by our Company has been missed out due to inadvertence. 'The figures for the quarter ended March 31, 2018 and March 31, 2017 are the balancing figures between the audited figures in respect of the full financial year and the unaudited published year to date figures up to the third quarter of the relevant financial year'...21-05-2018
Suven gets product patents for neurodegenerative disorders
Suven Life Sciences has been granted two product patents by Australia and one by Singapore corresponding to a new chemical entity (NCE) for the treatm17-05-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in Australia and Singapore17-05-2018
Fixes Book Closure for AGM
Suven Life Sciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 11, 2018 to August 14, 2018 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on August 14, 2018.16-05-2018
Suven Life Q4 net up 56% at Rs 62.5 cr
Drug firm Suven Life Sciences today reported a 56 per cent rise in standalone net profit to Rs 62.51 crore for the March quarter. It had posted a ne15-05-2018
Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed Investor Presentaion of our company15-05-2018